As AstraZeneca awaits an FDA decision for its Daiichi Sankyo-partnered Datroway in EGFR-mutated non-small cell lung cancer (NSCLC), the British pharma has rolled out early data from a trial ...

and EGFR, whereas MYC amplifications were present in KRAS G12C-mutated tumors in both pancreatic cancer patient cohorts. Most strikingly, patients with pancreatic cancer whose tumors possessed ...

Researchers have long known that there is a relationship between the cancer-associated gene MYC (pronounced "Mick") and exercise adaptation. When human muscles are exercised, MYC is found to ...